Product Information
GABAPENTIN 800 MG TABLET is a generic product labeled by TAGI Pharma Inc., priced at $0.1004 per EA under NDC 51224012160. Its NADAC has been published 296 times since Jul 10, 2019.
FDA first approved this application on Oct 26, 2017. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
800 mg/1
Manufacturer
TAGI Pharma Inc.NDC
51224012160
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA207057FDA Approved
10/26/2017
TE Code
AB1
On Market Since
5/1/2019
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 800 MG TABLET has been published 296 times since Jul 10, 2019, and over the history we have for it it has declined 22.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1004 per EA |
|---|---|
| All-time high | $0.1374 (Jan 15, 2020) |
| All-time low | $0.0799 (Nov 20, 2024) |
| Median price | $0.1255 |
| Average price | $0.1223 |
| Largest weekly change | -27.0% (Nov 20, 2024) |
| Weeks tracked | 296 |
| Tracking since | Jul 10, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-19.5%
5Y
-23.4%
All
-22.6%
Last surveyed Mar 5, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 20 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GABAPENTIN 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 800 MG TABLET, manufactured by TAGI Pharma Inc., is $0.1004 per EA (NDC 51224012160), effective Mar 5, 2025.
How has the price of GABAPENTIN 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 800 MG TABLET has declined 22.6%. It has been tracked across 296 weekly CMS publications since Jul 10, 2019.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 800 MG TABLET?
Since Jul 10, 2019, the NADAC for GABAPENTIN 800 MG TABLET has ranged from a low of $0.0799 (Nov 20, 2024) to a high of $0.1374 (Jan 15, 2020), with a median of $0.1255 per EA.
Are there cheaper alternatives to GABAPENTIN 800 MG TABLET?
Yes. 20 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GABAPENTIN 800 MG TABLET, is $0.0900 per EA — about 10% below GABAPENTIN 800 MG TABLET.
Who manufactures GABAPENTIN 800 MG TABLET?
GABAPENTIN 800 MG TABLET (NDC 51224012160) is labeled by TAGI Pharma Inc., and CMS classifies it as a generic product.